IRWD - Ironwood Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

IRWD is currently covered by 3 analysts with an average price target of $6.74. This is a potential upside of $2.04 (43.4%) from yesterday's end of day stock price of $4.7.

Ironwood Pharmaceuticals's activity chart (see below) currently has 129 price targets and 110 ratings on display. The stock rating distribution of IRWD is 33.33% BUY and 66.67% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 62.95% of the time, taking 138.38 days on average.

Highest price target for IRWD is $10, Lowest price target is $3.7, average price target is $6.74.

Most recent stock forecast was given by JASON BUTLER from JMP on 31-Mar-2026. First documented stock forecast 05-Nov-2014.

Currently out of the existing stock ratings of IRWD, 4 are a HOLD (66.67%), 2 are a BUY (33.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 25-Feb-2026

$10

$5.3 (112.77%)

$10

7 months 21 days ago
(31-Mar-2026)

0/5 (0%)

$6.49 (184.90%)

Hold Since 25-Feb-2026

$3.7

$-1 (-21.28%)

$17

8 months 26 days ago
(25-Feb-2026)

1/2 (50%)

$0.04 (1.09%)

6

Hold Since 05-Jan-2026

$5

$0.87 (21.07%)

10 months 16 days ago
(05-Jan-2026)

1/3 (33.33%)

$0.41 (8.93%)

16

Hold Since 28-Apr-2025

$1.7

$1.1

1 years 23 days ago
(29-Oct-2025)

2/6 (33.33%)

$0.19 (12.58%)

57

Hold Since 09-Sep-2024

$1

$5

1 years 7 months 7 days ago
(14-Apr-2025)

2/2 (100%)

$0.35 (53.85%)

90

Show more analysts

Please expand the browser size to see the chart

What is IRWD (Ironwood Pharmaceuticals) average time for price targets to be met?

On average it took 138 days for the stock forecasts to be reached, with an average price target met ratio of 62.95%.

Which analyst most recently updated their price target on IRWD (Ironwood Pharmaceuticals)?

Jason Butler

Which analyst has the most public recommendations on IRWD (Ironwood Pharmaceuticals)?

Jason Butler has 12 price targets and 10 ratings on IRWD

Which analyst is the currently most bullish on IRWD (Ironwood Pharmaceuticals)?

David Amsellem with the highest potential upside of $13.87

Which analyst is the currently most reserved on IRWD (Ironwood Pharmaceuticals)?

Faisal Khurshid with the lowest potential downside of -$3.7
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?